Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

HILS Hillstream BioPharma Inc

0,2305

0,00 (0,00%)

24 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Hillstream BioPharma (NASDAQ:HILS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Hillstream BioPharma Charts.

Hillstream BioPharma (NASDAQ:HILS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Hillstream BioPharma Charts.

News Hillstream BioPharma Inc

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 22 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Freitag 22 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 21 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Donnerstag 21 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 25 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
Donnerstag 21 September 2023 (8 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 12 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis
Montag 11 September 2023 (8 Monate vor) • GlobeNewswire Inc.

Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
Freitag 8 September 2023 (9 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 30 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Mittwoch 30 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 18 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Weitere Hillstream BioPharma Inc News-Artikel

Diversified Resources (GM)

RCM Technologies

Barclays Bank PLC

Societe Generale Societe...

Sport Lisboa BenficaFutS...

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen